Pediatrix Medical Group Inc reports results for the quarter ended in September 30 - Earnings Summary
01/11/2024 14:31
* Pediatrix Medical Group Inc MD.N reported quarterly
adjusted
earnings of 44 cents per share for the quarter ended September
30, higher than the same quarter last year, when the company
reported EPS of 32 cents. The mean expectation of
eight analysts for the quarter was for earnings of 37 cents per
share. Wall Street expected results to range from 34 cents to 39
cents per share.
* Revenue rose 0.9% to $511.16 million from a year ago;
analysts
expected $498.87 million.
* Pediatrix Medical Group Inc's reported EPS for the quarter
was
23 cents.
* The company reported quarterly net income of $19.44
million.
* Pediatrix Medical Group Inc shares had risen by 6.3% this
quarter and gained 32.5% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 3.5%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 6
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the healthcare
facilities & services peer group is "hold."
Wall Street's median 12-month price target for Pediatrix Medical
Group Inc is $11.75
This summary was machine generated from LSEG data November 1 at
02:31 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 0.37 0.44 Beat
Jun. 30 2024 0.31 0.34 Beat
Mar. 31 2024 0.19 0.20 Beat
Dec. 31 2023 0.33 0.32 Missed